"Direct Injections into Eye Show Promise for Treating Visual Illness" - Jane Farrell
Although most of us shiver at the idea of injecting medicine directly into the eye, that method may work better when it comes to treating the serious eye illness macular edema, research shows. The study, conducted by researchers at a number of institutions including Mount Sinai, was published in the journal Ophthalmology. Douglas Jabs, MD, professor and chair emeritus of ophthalmology at the Icahn School of Medicine at Mount Sinai and director of the Eye and Vision Research Institute at the New York Eye and Ear Infirmary of Mount Sinai, who conducted the research, said injections directly into the eye were clearly more effective. There could be a complication, though: Direct delivery of these corticosteroid medications to the eye can lead to greater pressure on the eye and glaucoma —a disease that causes optic nerve damage. But while more participants who received intravitreal delivery of corticosteroids showed a rise in eye pressure when compared to patients receiving periocular injections, this higher pressure was largely controlled with drugs.
— Douglas Jabs, MD, Professor, Chair Emeritus, Ophthalmology, Icahn School of Medicine at Mount Sinai, Director, The Eye and Vision Research Institute, New York Eye and Ear Infirmary of Mount Sinai
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Nov 17, 2022 View All Press ReleasesHigh-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Aug 02, 2022 View All Press ReleasesBlinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Jul 12, 2022 View All Press ReleasesThree Mount Sinai Ophthalmologists Receive Prestigious Achievement Awards
Dec 01, 2020 View All Press ReleasesBreakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections
Apr 13, 2020 View All Press Releases